The Current Ratio as of November 2024 (TTM) for Aptorum Group Limited (APM) is 1.18

According to Aptorum Group Limited’s latest financial reports and current stock price. The company's current Current Ratio is 1.18. This represents a change of 53.76% compared to the average of 0.77 of the last 4 quarters.

Aptorum Group Limited (APM) Historical Current Ratio (quarterly & annually)

How has APM Current Ratio performed in the past?

The mean historical Current Ratio of Aptorum Group Limited over the last ten years is 4.85. The current 1.18 Current Ratio has changed 2.33% with respect to the historical average. Over the past ten years (40 quarters), APM's Current Ratio was at its highest in in the June 2019 quarter at 12.97. The Current Ratio was at its lowest in in the February 2023 quarter at 0.

Aptorum Group Limited (APM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Aptorum Group Limited Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Aptorum Group Limited (APM) Average Current Ratio

How has APM Current Ratio performed in the past?

The current Current Ratio of Aptorum Group Limited (APM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Aptorum Group Limited (APM) Current Ratio vs. Peers

How is APM’s Current Ratio compared to its peers?

Aptorum Group Limited’s Current Ratio is less than ERYTECH Pharma S.A. (3.65), less than Surrozen, Inc. (7.40), less than Unicycive Therapeutics, Inc. (3.61), greater than Armata Pharmaceuticals, Inc. (0.19), less than Applied Molecular Transport Inc. (4.99), less than Fresh Tracks Therapeutics, Inc. (6.98), greater than AIM ImmunoTech Inc. (0.75), less than BioCardia, Inc. (1.78), less than Innate Pharma S.A. (2.92), less than Addex Therapeutics Ltd (4.97), less than Celyad Oncology SA (1.42), less than Dyadic International, Inc. (5.15), less than Altamira Therapeutics Ltd. (1.38), less than Dermata Therapeutics, Inc. (7.11), greater than ContraFect Corporation (0.53), greater than eFFECTOR Therapeutics, Inc. (1.03), greater than Aditxt, Inc. (0.09), less than NeuroBo Pharmaceuticals, Inc. (2.41), less than Revelation Biosciences, Inc. (1.64),

Build a custom stock screener for Aptorum Group Limited (APM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aptorum Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Aptorum Group Limited (APM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Aptorum Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.